"Radioimmunodetection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera.
| Descriptor ID |
D016719
|
| MeSH Number(s) |
E01.370.350.710.710 E01.370.384.730.710 E05.478.805
|
| Concept/Terms |
Radioimmunodetection- Radioimmunodetection
- Radioimmunodetections
- Immunoscintigraphy, Radiolabelled
- Immunoscintigraphies, Radiolabelled
- Radiolabelled Immunoscintigraphies
- Radioimmunoimaging
- Radioimmunoimagings
- Radiolabelled Immunoscintigraphy
- Immunoscintigraphy, Radiolabeled
- Radioimmunoscintigraphy
- Radioimmunoscintigraphies
- Radiolabeled Immunoscintigraphy
- Immunoscintigraphies, Radiolabeled
- Radiolabeled Immunoscintigraphies
|
Below are MeSH descriptors whose meaning is more general than "Radioimmunodetection".
Below are MeSH descriptors whose meaning is more specific than "Radioimmunodetection".
This graph shows the total number of publications written about "Radioimmunodetection" by people in this website by year, and whether "Radioimmunodetection" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 |
| 1995 | 1 | 2 | 3 |
| 1996 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radioimmunodetection" by people in Profiles.
-
Molecular imaging of Bcr-Abl phosphokinase in a xenograft model. Mol Cancer Ther. 2009 Mar; 8(3):703-10.
-
Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer. Mol Imaging. 2007 Mar-Apr; 6(2):131-9.
-
Recent advances in the treatment of childhood brain tumors. Pediatr Hematol Oncol. 2005 Jul-Aug; 22(5):361-71.
-
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):362-70.
-
Histologic confirmation of lesions identified by Prostascint scan following definitive treatment. Urol Oncol. 2003 Sep-Oct; 21(5):349-52; discussion 353.
-
Poly(ethylene glycol)-conjugated anti-EGF receptor antibody C225 with radiometal chelator attached to the termini of polymer chains. Bioconjug Chem. 2001 Jul-Aug; 12(4):545-53.
-
Radioimmunoguided imaging of prostate cancer foci with histopathological correlation. Int J Radiat Oncol Biol Phys. 2001 Apr 01; 49(5):1281-6.
-
Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors. J Nucl Med. 2000 Feb; 41(2):355-62.
-
99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection. Br J Cancer. 1998; 77(1):131-8.
-
Hematologic side effects of radiolabeled immunoglobulin therapy. Exp Hematol. 1996 Aug; 24(10):1183-90.